Frederick M. Dirbas
Clinical Trials
- Not Recruiting Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
- Not Recruiting Phase II Anastrozole and ZD6474 in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast Cancer
- Not Recruiting Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer
- Recruiting Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
- Not Recruiting Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer
- Recruiting A Pharmacokinetic and Randomized Trial of Neoadjuvant Treatment With Anastrozole Plus AZDO530 in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer
Help
Trial Administration